주사용 약물전달 시장 : 디바이스 유형별, 재료 유형별, 사용성별, 투여 경로별, 최종사용자별, 지역별

Injectable Drug Delivery Market is estimated to be valued at USD 650 Bn in 2026 and is expected to reach USD 900 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

Injectables offer maximum bioavailability of drugs towards the intended site of action and avoid the first pass metabolism. The injectable route is mostly preferred for the drugs which can't be taken orally or have some stability problems. Unconscious patients or patients having low compliance towards oral tablets or capsules can be preferred for the injectable drug delivery therapy.

Market Dynamics

Increasing prevalence of chronic diseases such as diabetes, cardiac diseases, and anaphylaxis has supported growth of global injectable drug delivery market. According to the Allergy, Asthma & Clinical Immunology, in 2015, around 15 million people suffered from food allergies in the U.K. Similarly, according to the European Academy of Allergy and Clinical Immunology (EAACI), in 2015, around 17 million people suffered from food allergies in the U.K., of which around 3.5 million were children. Increasing awareness regarding safety and concern of needlestick injuries is a major factor driving growth of the injectable drug delivery market. For instance, the WHO recommended the use of safety syringes with sharp injury protection (SIP), in order to prevent needlestick injuries. Similarly, in May 2017, Innovative Neurons LLC announced to commercialize its patented auto retractable multi-needle syringe known as FAST (fast, accessible, safe, and technology) to decrease needlestick injuries. Various market players are focusing on the development and advancement in this space. For instance, ACT-O-VIAL System offered by Pfizer Inc. is a dual-component vial system that allows reconstitution of sterile, injectable medications by pressing on the plastic cap. The facility launch by market players to cater requirements of patients is expected to drive the market growth. For instance, in July 2018, Pfizer, Inc. announced to build sterile injectable pharmaceutical production facilities in the Michigan, U.S.

However, product recalls by the manufacturers is the major factors restraining the market over the forecast period. For instance, in April 2018, Becton Dickson and Company announced a recall of PosiFlush Heaparin Lock Flush Syringe, and Prefilled normal saline syringe, owing to the contamination with Serratia marcescens bacterium.

Key features of the study

• This report provides in-depth analysis of the injectables drug delivery market and provides market size (USD million) and compound annual growth rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global injectable drug delivery market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, Injex Pharma GmbH.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global injectables drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injectable drug delivery market

Market Segmentation

• Device Type Insights (Revenue, USD Bn, 2026 - 2033)
  • Prefilled Syringes
  • Auto Injectors
  • Pens
  • Conventional Syringes
  • Cartridges
  • Ampoules
  • Vials
  • Others
• Material Type Insights (Revenue, USD Bn, 2026 - 2033)
  • Glass
  • Plastic
• Usability Insights (Revenue, USD Bn, 2026 - 2033)
  • Disposable
  • Reusable
• Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
  • Intravenous
  • Intramuscular
  • Subcutaneous
• End User Insights (Revenue, USD Bn, 2026 - 2033)
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Key Players Insights
  • Becton, Dickinson and Company
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Gerresheimer AG
  • Carl-Zeiss-Stiftung
  • Terumo Corporation
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • SHL Group
  • Owen Mumford Limited
  • Injex Pharma GmbH

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Injectable Drug Delivery Market, By Device Type
  • Global Injectable Drug Delivery Market, By Material Type
  • Global Injectable Drug Delivery Market, By Usability
  • Global Injectable Drug Delivery Market, By Route of Administration
  • Global Injectable Drug Delivery Market, By End User
  • Global Injectable Drug Delivery Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Injectable Drug Delivery Market, By Device Type, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Prefilled Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Auto Injectors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Pens
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Conventional Syringes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Cartridges
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Ampoules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Vials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. Global Injectable Drug Delivery Market, By Material Type, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Glass
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Plastic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Injectable Drug Delivery Market, By Usability, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Disposable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Reusable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

7. Global Injectable Drug Delivery Market, By Route of Administration, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Intramuscular
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Subcutaneous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

8. Global Injectable Drug Delivery Market, By End User, 2020-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

9. Global Injectable Drug Delivery Market, By Region, 2020 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Device Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Usability, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novo Nordisk A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Gerresheimer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Carl-Zeiss-Stiftung
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vetter Pharma-Fertigung GmbH & Co. KG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SHL Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Owen Mumford Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Injex Pharma GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us